Nilotinib and malignant neoplasm progression Patient Reports February 11, 2012
Nilotinib Side Effects Report #5597232-6
Nilotinib side effect was reported by a Physician from SPAIN on Jan 16, 2008. Male patient, 70 years of age, weighting 132.3 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Nilotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, cardiac failure, concomitant disease progression, fatigue, hepatic failure, malignant neoplasm progression, mental status changes. Nilotinib dosage: 800 MG, QD. During the same period patient was treated with FUROSEMIDE, INSULIN, ASPIRIN, SUNITINIB MALATE. Patient was hospitalized. Patient died on 11/08/2007.Nilotinib Side Effects Report #5640570-9
Nilotinib side effect was reported by a Physician from POLAND on Feb 21, 2008. Female patient, 66 years of age, weighting 163.1 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Nilotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, ileus, malignant neoplasm progression, nausea
, tumour excision, tumour necrosis. Nilotinib dosage: 800MG DAILY. Patient was hospitalized and became disabled. Patient died on 12/15/2007.Nilotinib Side Effects Report #5510963-9
Nilotinib side effect was reported by a Physician from CANADA on Nov 01, 2007. Female patient, 59 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with Nilotinib. After drug was administered, patient experienced the following side effects: anaemia, asthenia, gastrointestinal pain, malignant neoplasm progression, nausea
. Nilotinib dosage: 400 MG, BID. Patient was hospitalized. Patient recovered.Nilotinib Side Effects Report #5607529-9
Nilotinib side effect was reported by a Physician from UNITED STATES on Jan 22, 2008. Female patient, 53 years of age, weighting 205.3 lb, was diagnosed with gastrointestinal stromal tumour, diarrhoea, pulmonary embolism
, pain
and was treated with Nilotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, dehydration, diarrhoea, gastrointestinal tube insertion, hypotension, intestinal obstruction, malignant neoplasm progression, syncope. Nilotinib dosage: 400 MG, BID. During the same period patient was treated with IMODIUM, LASIX, LOVENOX, MORPHINE. Patient was hospitalized. Patient recovered.Nilotinib Side Effects Report #5572902-4
Nilotinib side effect was reported by a Physician from GERMANY on Dec 20, 2007. Female patient, 50 years of age, weighting 163.1 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Nilotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Nilotinib dosage: 400 MG, BID. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ONDANSETRON. Patient died on 10/30/2007.
Nilotinib Side Effects Report #5718768-0
Nilotinib side effect was reported by a Physician from CANADA on Apr 21, 2008. Male patient, 36 years of age, was diagnosed with acute biphenotypic leukaemia and was treated with Nilotinib. After drug was administered, patient experienced the following side effects: acute lymphocytic leukaemia, malignant neoplasm progression. Nilotinib dosage: 400 MG, BID. During the same period patient was treated with MS CONTIN. Patient died on 01/05/2007.
Nilotinib and malignant neoplasm progression 